Roche Holding AG operates in the fields of pharmaceuticals and diagnostics worldwide. It discovers, develops, and provides diagnostic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, and treatment of diseases. The company provides in-vitro diagnostics instruments and tests for the early detection and diagnosis of cancer. It is also involved in the research and development, and marketing of pharmaceutical products primarily in the therapeutic areas of oncology, virology, inflammation, metabolic disorders, and central nervous system. In addition, the company provides a portfolio of diagnostics products, such as blood glucose meters for diabetes patients; point-of-care testing devices for the doctors; high-throughput analyzers for hospitals and commercial diagnostic laboratories; and start-of-the-art instruments and reagents for life science research. Further, the company offers integrated cobas, a solution for blood serum testing in commercial and hospital labs, medical centers, and laboratory networks. Roche Holding AG also offers various products for researchers in the areas of amplification, cell analysis, gene expression, genome sequencing, microarrays, nucleic acid purification, protein analysis, real-time PCR systems, and transfection. It has strategic alliances with Technoclone and Med Fusion, LLC, as well as a strategic collaboration with AREVA Med LLC. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Key Statistics